FR2386523B1 - - Google Patents

Info

Publication number
FR2386523B1
FR2386523B1 FR7810063A FR7810063A FR2386523B1 FR 2386523 B1 FR2386523 B1 FR 2386523B1 FR 7810063 A FR7810063 A FR 7810063A FR 7810063 A FR7810063 A FR 7810063A FR 2386523 B1 FR2386523 B1 FR 2386523B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7810063A
Other languages
French (fr)
Other versions
FR2386523A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of FR2386523A1 publication Critical patent/FR2386523A1/fr
Application granted granted Critical
Publication of FR2386523B1 publication Critical patent/FR2386523B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7810063A 1977-04-05 1978-04-05 Derives du prostane et medicaments qui en contiennent Granted FR2386523A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772715838 DE2715838A1 (de) 1977-04-05 1977-04-05 Neue prostanderivate und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
FR2386523A1 FR2386523A1 (fr) 1978-11-03
FR2386523B1 true FR2386523B1 (de) 1981-02-13

Family

ID=6005974

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7810063A Granted FR2386523A1 (fr) 1977-04-05 1978-04-05 Derives du prostane et medicaments qui en contiennent

Country Status (11)

Country Link
JP (1) JPS53124238A (de)
BE (1) BE865705A (de)
CH (1) CH638773A5 (de)
DE (1) DE2715838A1 (de)
DK (1) DK150778A (de)
FR (1) FR2386523A1 (de)
GB (1) GB1601994A (de)
IE (1) IE46864B1 (de)
IT (1) IT1093506B (de)
LU (1) LU79369A1 (de)
NL (1) NL7803415A (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2654113A1 (de) * 1976-11-29 1978-06-01 Merck Patent Gmbh Prostaglandinartige verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5972991A (en) 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US5385945A (en) * 1992-10-21 1995-01-31 Allergan, Inc. 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds
WO2001066518A1 (fr) * 2000-03-09 2001-09-13 Ono Pharmaceutical Co., Ltd. E-ALCOOLS PHENYL-PROSTAGLANDINE φ-SUBSTITUES, PROCEDE DE PREPARATION ASSOCIE ET MEDICAMENTS RENFERMANT CES DERNIERS EN TANT QUE PRINCIPE ACTIF
US7183310B2 (en) 2004-08-10 2007-02-27 Allergan, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US7101906B2 (en) * 2004-11-16 2006-09-05 Allergan, Inc. 2,3,4-substituted cyclopentanones as therapeutic agents
US7183324B2 (en) 2004-11-23 2007-02-27 Allergan, Inc. 2,3,4-substituted cyclopentanones as therapeutic agents
WO2010102078A1 (en) 2009-03-04 2010-09-10 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US7851504B2 (en) 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
DK1960353T3 (da) 2005-11-03 2014-05-26 Allergan Inc Prostaglandiner og analoger som midler til sænkning af intraokulært tryk

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1468830A (en) * 1974-01-26 1977-03-30 May & Baker Ltd Cyclopentane derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure

Also Published As

Publication number Publication date
NL7803415A (nl) 1978-10-09
FR2386523A1 (fr) 1978-11-03
IT1093506B (it) 1985-07-19
IE780671L (en) 1978-10-05
BE865705A (fr) 1978-10-05
LU79369A1 (de) 1978-07-13
IT7821951A0 (it) 1978-04-04
CH638773A5 (en) 1983-10-14
GB1601994A (en) 1981-11-04
DK150778A (da) 1978-10-06
IE46864B1 (en) 1983-10-19
JPS53124238A (en) 1978-10-30
DE2715838A1 (de) 1978-10-19

Similar Documents

Publication Publication Date Title
FR2386523B1 (de)
AU3353778A (de)
AU495917B2 (de)
AR210643A1 (de)
AU71461S (de)
BG25812A1 (de)
BG25855A1 (de)
BE851449A (de)
BG25819A1 (de)
BE866391A (de)
BE868323A (de)
BE870787A (de)
BE871419A (de)
BE871991A (de)
BE872973A (de)
BE873002A (de)
BG23438A1 (de)
BG23462A1 (de)
BG24331A1 (de)
BG24713A1 (de)
BG25808A1 (de)
BG25809A1 (de)
BG25822A1 (de)
BG25811A1 (de)
BG25840A1 (de)

Legal Events

Date Code Title Description
ST Notification of lapse